Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 4/2010

01-08-2010 | Case Report

Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis

Authors: M. Vetter, M. Battegay, M. Trendelenburg

Published in: Infection | Issue 4/2010

Login to get access

Abstract

A 70 year-old female patient presented with fever, nausea and dyspnea. She had been receiving immunosuppressive therapy with methotrexate and prednisone for large-vessel vasculitis. The patient was shown to have coexistent Pneumocystis jiroveci pneumonia and primary cytomegalovirus (CMV) infection with presumed CMV pneumonitis and colitis. To our knowledge, this is the first case report on the occurrence of combined primary cytomegalovirus and Pneumocystis jiroveci infection in a patient with vasculitis. It illustrates the importance of being aware of the possibility of combined opportunistic infections in patients with rheumatologic diseases.
Literature
1.
Hedderwick SA, Bonilla HF, Bradley SF, Kauffman CA. Opportunistic infections in patients with temporal arteritis treated with corticosteroids. J Am Geriatr Soc. 1997;45:334–7.PubMed
2.
Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, et al. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener’s granulomatosis. Am J Respir Crit Care Med. 1995;151:795–9.PubMed
3.
Sendi P, Wolf A, Graber P, Zimmerli W. Multiple opportunistic infections after high-dose steroid therapy for giant cell arteritis in a patient previously treated with a purine analog. Scand J Infect Dis. 2006;38:922–4.CrossRefPubMed
4.
Staples PJ, Gerding DN, Decker JL, Gordon RS Jr. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum. 1974;17:1–10.CrossRefPubMed
5.
Sneller MC. Evaluation, treatment, and prophylaxis of infections complicating systemic vasculitis. Curr Opin Rheumatol. 1998;10:38–44.CrossRefPubMed
6.
Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis. 2006;43:1143–51.CrossRefPubMed
7.
Lübeck PR, Doerr HW, Rabenau HF. Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol. 2010;199:53–60. (Epub 2009 Dec 1).CrossRefPubMed
8.
Merigan TC. Immunosuppression and herpesviruses. In: Nahmias AJ, Dowdle WR, Schinazi RF editors, The human herpesviruses: an interdisciplinary perspective. New York: Elsevier, 1981:309–22.
9.
Wreghitt TG, Teare EL, Sule O, Devi R, Rice P. Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis. 2003;37:1603–6.CrossRefPubMed
10.
Griffiths PD. Current management of cytomegalovirus disease. J Med Virol. 1993;1:106–11.
11.
Sutherland S, Bracken P, Wreghitt TG, O’Grady J, Calne RY, Williams R. Donated organ as a source of cytomegalovirus in orthotopic liver transplantation. J Med Virol. 1992;37:170–3.CrossRefPubMed
12.
Boeckh M, Nichols WG. Immunosuppressive effects of beta-herpesviruses. Herpes. 2003;10:12–6.PubMed
13.
Samuel R, Bettiker RL, Suh B. AIDS related opportunistic infections, going but not gone. Arch Pharm Res. 2002;25:215–28.CrossRefPubMed
14.
15.
Wreghitt TG, Teare EL, Sule O, Devi R, Rice P. Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis. 2003;37:1603–6.CrossRefPubMed
16.
Mann M, Shelhamer JH, Masur H, Gill VJ, Travis W, Solomon D, et al. Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection. Am J Respir Crit Care Med. 1997;155:1723–8.PubMed
17.
Jensen AM, Lundgren JD, Benfield T, Nielsen TL, Vestbo J. Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution. Chest. 1995;108:411–4.CrossRefPubMed
18.
Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis. 2002;185:273–82 (Epub 2002 Jan 17).
19.
Greenberg SB. Infections in the immunocompromised rheumatologic patient. Crit Care Clin. 2002;18:931–56.CrossRefPubMed
20.
Mounzer KC, DiNubile MJ. Prophylactic use of antibiotics and vaccines in patients with rheumatologic disorders. Rheum Dis Clin North Am. 1997;23:259–75.CrossRefPubMed
Metadata
Title
Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis
Authors
M. Vetter
M. Battegay
M. Trendelenburg
Publication date
01-08-2010
Publisher
Urban and Vogel
Published in
Infection / Issue 4/2010
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0024-1

Other articles of this Issue 4/2010

Infection 4/2010 Go to the issue

Correspondence

Psychiatric manifestations as the leading symptom in an expatriate with dengue fever

Clinical and Epidemiological Study

Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules

Brief Report

Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA

Clinical and Epidemiological Study

Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection

Clinical and Epidemiological Study

Prognostic factors of the mortality of postoperative intraabdominal infections

Correspondence

Rothia aeria acute bronchitis: the first reported case

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits